Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

Drug Delivery: Inhalation Devices

This Meddevicetracker report includes a discussion of inhalation devices, products, current/forecast markets, competitors, and opportunities in the global markets for inhalation-based drug delivery devices for the treatment of asthma and COPD and much more.

December 14, 2021

Find out more

Blood Gas Monitoring Systems

$4,750.00

Arterial blood gases are the most commonly ordered test in critical care settings such as ICUs and ORs.Tests with rapid turnaround times, such as POC tests, are largely replacing the slower laboratory test market.

March 28, 2019

Find out more

Liquid Biopsy Oncology Market

$4,750.00

This comprehensive medical market and technology report provides an overview and in-depth market analysis of liquid biopsy products used in the field of oncology. In 2020, the global market for liquid biopsy products for oncology applications was valued at approximately $1.9bn.

October 11, 2021

Find out more

United States, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the prevalence and number of hospital discharges in the UnitedStates (U.S.) as well as the surgical procedure volumes for selected cardiovascular/thoracic diseases/disorders.

January 1, 2013

Find out more

France, Surgical Procedure Volumes

$4,850.00

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the EU country of France.

August 1, 2013

Find out more

Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration – 2021

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration. Geographic markets covered by this analysis comprise the US, Japan, five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW), which includes all other countries.

November 2, 2021

Find out more

Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Therapies

$4,750.00

Approximately 16.3 million adults in the United States (U.S.) suffer from coronaryheart disease (CHD), a type of cardiovascular disease that is associated with areduction in blood flow through the vasculature of the heart (ischemic heart disease).

March 1, 2013

Find out more

Women’s Health: Market for Minimally Invasive Female Urinary Incontinence Devices

$3,750.00

This report focuses on minimally invasive therapy systems designed for the treatment of female urinary incontinence (UI); market segments covered include injectable urethral bulking agents, urethral sling systems, and neuromodulation systems.

December 19, 2016

Find out more

U.S. Markets for Orthopedic Extremity and Soft Tissue Repair, September 2015

$5,250.00

The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury.

September 1, 2015

Find out more

Hip Replacement Implants Market

$4,750.00

An aging global population and increasing life expectancy are driving growth in the global market for hip replacement implants. This market is expected to grow at a CAGR of 2.1% over the forecast period, reaching a value of nearly $7bn in the year 2024.

October 22, 2020

Find out more

Triple-Negative Breast Cancer KOL Interview – UK

$599.00

A UK-based key opinion leader providers insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for triple- negative breast cancer. Diagnostic testing, biomarker disease segmentation, and unmet needs are also discussed. Key pipeline assets highlighted include balixafortide, Keytruda, sacituzumab govitecan, trastuzumab deruxtecan, and veliparib.

October 31, 2019

Find out more

Biomedtracker Early 2021 Outlook Report

$4,750.00

In this report, we cover catalysts from 28 drugs, devices, diagnostics, and deals expected to occur in early 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

February 1, 2021

Find out more

U.S. Markets for Cardiac Rhythm Management Products, February 2015

$4,750.00

Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it.

February 2, 2015

Find out more

MedTech analysis

Drug Delivery: Inhalation Devices

Blood Gas Monitoring Systems

Liquid Biopsy Oncology Market

United States, Cardiovascular Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

France, Surgical Procedure Volumes

Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration – 2021

Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Therapies

Women’s Health: Market for Minimally Invasive Female Urinary Incontinence Devices

U.S. Markets for Orthopedic Extremity and Soft Tissue Repair, September 2015

Hip Replacement Implants Market

Triple-Negative Breast Cancer KOL Interview – UK

Biomedtracker Early 2021 Outlook Report

U.S. Markets for Cardiac Rhythm Management Products, February 2015